Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Migraine

Free Subscription 05.01.2026 1 BMC Neurol 1 Cephalalgia 4 Headache 2 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. VASIREDDY S, Biswas S, Kollu R, Krishnan E, et al
   Comparative effectiveness and safety of preventive treatments for vestibular migraine: a systematic review and network meta-analysis.
   BMC Neurol. 2025;25:513.
   PubMed         Abstract available
   
   

   
   Cephalalgia

2. ASHINA M, Tassorelli C, Kokturk P, Akcicek H, et al
   Addressing unmet needs in migraine: Real-world fremanezumab effectiveness in participants of the PEARL study with at least three prior preventive treatment failures.
   Cephalalgia. 2025;45:3331024251395029.
   PubMed         Abstract available
   
   

   
   Headache

3. CHENG N, Anderson CC, Zhang N, VanderPluym JH, et al
   Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham-controlled study.
   Headache. 2025 Dec 31. doi: 10.1111/head.70032.
   PubMed         Abstract available
   
   
4. SCHUSTER NM, Wallace MS, Marcotte TD, Buse DC, et al
   Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trial.
   Headache. 2025 Dec 30. doi: 10.1111/head.70025.
   PubMed         Abstract available
   
   
5. GRANT TEJADA MP, Klomhaus AM, Ortiz R, Tibbe TD, et al
   Migraine prevalence and phenotype in autism: A retrospective cohort study using a US National Health Survey and large academic health system electronic health record.
   Headache. 2025 Dec 29. doi: 10.1111/head.70035.
   PubMed         Abstract available
   
   
6. SCHINDLER EAD, Gottschalk CH, Pittman BP, D'Souza DC, et al
   Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.
   Headache. 2025 Dec 29. doi: 10.1111/head.70024.
   PubMed         Abstract available
   
   

   
   Rev Neurol (Paris)

7. HASIRCI BAYIR BR, Ulutas C, Nazli E, Koklu H, et al
   The role of kynurenine pathway metabolites in clinical features and chronic migraine.
   Rev Neurol (Paris). 2025 Dec 24:S0035-3787(25)00657.
   PubMed         Abstract available
   
   
8. HENRI J, Redon S, Donnet A
   Refining the definition of severe migraine: Evidence from a prospective observational study.
   Rev Neurol (Paris). 2025 Dec 22:S0035-3787(25)00658.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.